Citalopram hydrobromide is a salt form of Citalopram (sc-201123). Citalopram is a selective inhibitor of ST (5-hydroxytryptamine/serotonin transporter) and therefore is a potent and selective serotonin reuptake inhibitor. Additional studies in indicate that Citalopram may be a weak, allosteric modulator of serotonin in a cross-species chimeric study. Studies also indicate that Citalopram is useful for studying gene expression patterns in circulating lymphocytes. In zebrafish, Citalopram is noted to reduce the frequency of NMDA-induced locomotor rhythm involved in swimming behavior.
Citalopram HBR
Description | |
---|---|
1-[3-(Dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile mono hydrobromide | |
59729-32-7 | |
C20H21FN2O.Hbr | |
ERDOSTEIN;CITALOPRAM HBR;Citalopram-D4Br;CitalopraM HBr API;Citalopramehydrobromide;CITALOPRAM HYDROBROMIDE;CITALOPRAM BROMOHYDRATE;Citaloplam hydrobromide;CitalopraM HydrobroMide, USP;(+/-)-CITALOPRAM HYDROBROMIDE | |
Anti-depressant/Anti-psychotic |